BNP Paribas Financial Markets’s Tevogen Inc. Common Stock TVGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$685 Sell
121
-161
-57% -$1.28K ﹤0.01% 5645
2026
Q1
$1.27K Buy
282
+12
+4% +$147 ﹤0.01% 5455
2025
Q4
$4.48K Buy
270
+88
+48% +$2.29K ﹤0.01% 5271
2025
Q3
$7.15K Sell
182
-21
-10% -$1.03K ﹤0.01% 5058
2025
Q2
$12.7K Buy
203
+54
+36% +$3.08K ﹤0.01% 4787
2025
Q1
$8.04K Sell
149
-69
-32% -$4.54K ﹤0.01% 4772
2024
Q4
$11.2K Sell
218
-61
-22% -$3.97K ﹤0.01% 4833
2024
Q3
$5.14K Buy
279
+248
+800% +$7.25K ﹤0.01% 3841
2024
Q2
$1.14K Buy
+31
New +$2.02K ﹤0.01% 3858

Other funds holding TVGN

BNP Paribas Financial Markets's TVGN Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its Tevogen Inc. Common Stock (TVGN) stake by 57% in Q2 2026, selling an estimated $1.28K and leaving 121 shares worth $685. The position accounts for ﹤0.01% of the portfolio, ranked #5645.

BNP Paribas Financial Markets first reported a position in TVGN in Q2 2024 and has held it in 9 quarters since. The position peaked at $12.7K in Q2 2025. 27 funds tracked by Wall St. Rank hold TVGN as of Q2 2026.

  • BNP Paribas Financial Markets held 121 shares of Tevogen Inc. Common Stock worth $685 as of Q2 2026.
  • BNP Paribas Financial Markets sold 161 Tevogen Inc. Common Stock shares in Q2 2026, an estimated $1.28K.
  • Tevogen Inc. Common Stock made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5645 holding.
  • BNP Paribas Financial Markets first reported a position in Tevogen Inc. Common Stock in Q2 2024 and has held it in 9 quarters since.
  • BNP Paribas Financial Markets's Tevogen Inc. Common Stock position peaked at $12.7K in Q2 2025.
  • 27 funds tracked by Wall St. Rank held Tevogen Inc. Common Stock as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.